South Korea Molecular Diagnostics Market Size, Share, Trends and Forecast by Product, Technology, Application, End User, and Region, 2026-2034
The South Korea molecular diagnostics market size reached USD 427.2 Million in 2025. The market is projected to reach USD 835.9 Million by 2034, exhibiting a growth rate (CAGR) of 7.51% during 2026-2034. The market is expanding due to the increasing adoption of precision medicine, rising cancer cases, and demand for advanced diagnostic tools. Additionally, strong investment in biomarker research and digital health technologies continues to support South Korea molecular diagnostics market share across clinical laboratories, hospitals, and research institutions.
SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET TRENDS:
Rising Focus on Personalized Cancer Diagnostics
The South Korea molecular diagnostics market growth is being propelled by the increasing demand for personalized medicine, particularly in oncology. As cancer prevalence continues to rise, healthcare providers and diagnostic companies are focusing on solutions that enable early detection and precise identification of genetic mutations. These advances allow for targeted therapies and reduce the risk of ineffective treatments, improving both patient outcomes and healthcare efficiency. Precision diagnostics are becoming a foundational element in clinical decision-making, especially as payers and providers emphasize value-based care. The push toward integrating biomarker-based diagnostics into routine cancer treatment is reshaping diagnostic protocols nationwide. In October 2024, Ngenebio launched the Oncoaccupanel RNA diagnostic panel in South Korea for detecting oncogenic fusion genes in solid tumors. This RNA-based diagnostic panel supports the identification of fusion genes critical in cancer progression and therapy selection. Its adoption underscores a growing national focus on personalized diagnostic tools that enhance accuracy and therapeutic alignment. The integration of such advanced panels into oncology workflows reflects a larger trend of investing in molecular-level insights for better patient management. With government backing and growing hospital infrastructure, South Korea is rapidly becoming a hub for innovative cancer diagnostics, reinforcing the expansion and depth of its molecular diagnostics capabilities in real-world clinical settings.
Technology Integration and Strategic Partnerships
The strategic alignment of biotechnology and digital platforms through collaborative partnerships is positively impacting the market expansion. Diagnostic innovation increasingly depends on combining high-quality biomarker research with advanced data analytics and automation to support fast, reliable testing services. These collaborations are not only improving diagnostic precision but also enabling scalable platforms for broader clinical use. South Korean firms are recognizing the value of integrating hardware, software, and biological research to provide seamless, end-to-end diagnostic solutions that address the full spectrum of patient care. This technology-first mindset is enabling rapid turnaround times, improving workflow efficiency, and ensuring high reliability in test outcomes. In August 2024, Hitachi High-Tech partnered with South Korea’s Gencurix to advance cancer molecular diagnostics by combining biomarker discovery with digital technology. This partnership aimed to build highly accurate, personalized cancer testing services and is part of a broader strategy to meet growing demand for real-time, actionable diagnostic information. The collaboration illustrates a shift toward technology-driven diagnostics, moving beyond traditional testing models. It also highlights how cross-border and cross-sector partnerships are becoming essential in elevating diagnostic service delivery in South Korea. As a result, the market is witnessing stronger integration of molecular diagnostics into hospital systems and research labs, creating new opportunities for growth and innovation.
SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional level for 2026-2034. Our report has categorized the market based on product, technology, application, and end user.
Product Insights:
Technology Insights:
Application Insights:
End User Insights:
Regional Insights:
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea molecular diagnostics market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea molecular diagnostics market on the basis of product?
What is the breakup of the South Korea molecular diagnostics market on the basis of technology?
What is the breakup of the South Korea molecular diagnostics market on the basis of application?
What is the breakup of the South Korea molecular diagnostics market on the basis of end user?
What is the breakup of the South Korea molecular diagnostics market on the basis of region?
What are the various stages in the value chain of the South Korea molecular diagnostics market?
What are the key driving factors and challenges in the South Korea molecular diagnostics market?
What is the structure of the South Korea molecular diagnostics market and who are the key players?
What is the degree of competition in the South Korea molecular diagnostics market?
SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET TRENDS:
Rising Focus on Personalized Cancer Diagnostics
The South Korea molecular diagnostics market growth is being propelled by the increasing demand for personalized medicine, particularly in oncology. As cancer prevalence continues to rise, healthcare providers and diagnostic companies are focusing on solutions that enable early detection and precise identification of genetic mutations. These advances allow for targeted therapies and reduce the risk of ineffective treatments, improving both patient outcomes and healthcare efficiency. Precision diagnostics are becoming a foundational element in clinical decision-making, especially as payers and providers emphasize value-based care. The push toward integrating biomarker-based diagnostics into routine cancer treatment is reshaping diagnostic protocols nationwide. In October 2024, Ngenebio launched the Oncoaccupanel RNA diagnostic panel in South Korea for detecting oncogenic fusion genes in solid tumors. This RNA-based diagnostic panel supports the identification of fusion genes critical in cancer progression and therapy selection. Its adoption underscores a growing national focus on personalized diagnostic tools that enhance accuracy and therapeutic alignment. The integration of such advanced panels into oncology workflows reflects a larger trend of investing in molecular-level insights for better patient management. With government backing and growing hospital infrastructure, South Korea is rapidly becoming a hub for innovative cancer diagnostics, reinforcing the expansion and depth of its molecular diagnostics capabilities in real-world clinical settings.
Technology Integration and Strategic Partnerships
The strategic alignment of biotechnology and digital platforms through collaborative partnerships is positively impacting the market expansion. Diagnostic innovation increasingly depends on combining high-quality biomarker research with advanced data analytics and automation to support fast, reliable testing services. These collaborations are not only improving diagnostic precision but also enabling scalable platforms for broader clinical use. South Korean firms are recognizing the value of integrating hardware, software, and biological research to provide seamless, end-to-end diagnostic solutions that address the full spectrum of patient care. This technology-first mindset is enabling rapid turnaround times, improving workflow efficiency, and ensuring high reliability in test outcomes. In August 2024, Hitachi High-Tech partnered with South Korea’s Gencurix to advance cancer molecular diagnostics by combining biomarker discovery with digital technology. This partnership aimed to build highly accurate, personalized cancer testing services and is part of a broader strategy to meet growing demand for real-time, actionable diagnostic information. The collaboration illustrates a shift toward technology-driven diagnostics, moving beyond traditional testing models. It also highlights how cross-border and cross-sector partnerships are becoming essential in elevating diagnostic service delivery in South Korea. As a result, the market is witnessing stronger integration of molecular diagnostics into hospital systems and research labs, creating new opportunities for growth and innovation.
SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional level for 2026-2034. Our report has categorized the market based on product, technology, application, and end user.
Product Insights:
- Reagents and Kits
- Instruments
- Software and Services
Technology Insights:
- Polymerase Chain Reactions (PCR)
- Hybridization
- DNA Sequencing
- Microarray
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Others
Application Insights:
- Infectious Diseases Diagnostics
- Oncology
- Genetic Testing
- Blood Screening
- Others
End User Insights:
- Hospitals
- Laboratories
- Others
Regional Insights:
- Seoul Capital Area
- Yeongnam (Southeastern Region)
- Honam (Southwestern Region)
- Hoseo (Central Region)
- Others
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea molecular diagnostics market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea molecular diagnostics market on the basis of product?
What is the breakup of the South Korea molecular diagnostics market on the basis of technology?
What is the breakup of the South Korea molecular diagnostics market on the basis of application?
What is the breakup of the South Korea molecular diagnostics market on the basis of end user?
What is the breakup of the South Korea molecular diagnostics market on the basis of region?
What are the various stages in the value chain of the South Korea molecular diagnostics market?
What are the key driving factors and challenges in the South Korea molecular diagnostics market?
What is the structure of the South Korea molecular diagnostics market and who are the key players?
What is the degree of competition in the South Korea molecular diagnostics market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET LANDSCAPE
5.1 Historical and Current Market Trends ???(??2020-2025?)
5.2 Market Forecast ???(?2026-2034??)
6 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET - BREAKUP BY PRODUCT
6.1 Reagents and Kits
6.1.1 Overview
6.1.2 Historical and Current Market Trends ???(??2020-2025?)
6.1.3 Market Forecast ???(?2026-2034??)
6.2 Instruments
6.2.1 Overview
6.2.2 Historical and Current Market Trends ???(??2020-2025?)
6.2.3 Market Forecast ???(?2026-2034??)
6.3 Software and Services
6.3.1 Overview
6.3.2 Historical and Current Market Trends ???(??2020-2025?)
6.3.3 Market Forecast ???(?2026-2034??)
7 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET - BREAKUP BY TECHNOLOGY
7.1 Polymerase Chain Reactions (PCR)
7.1.1 Overview
7.1.2 Historical and Current Market Trends ???(??2020-2025?)
7.1.3 Market Forecast ???(?2026-2034??)
7.2 Hybridization
7.2.1 Overview
7.2.2 Historical and Current Market Trends ???(??2020-2025?)
7.2.3 Market Forecast ???(?2026-2034??)
7.3 DNA Sequencing
7.3.1 Overview
7.3.2 Historical and Current Market Trends ???(??2020-2025?)
7.3.3 Market Forecast ???(?2026-2034??)
7.4 Microarray
7.4.1 Overview
7.4.2 Historical and Current Market Trends ???(??2020-2025?)
7.4.3 Market Forecast ???(?2026-2034??)
7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.5.1 Overview
7.5.2 Historical and Current Market Trends ???(??2020-2025?)
7.5.3 Market Forecast ???(?2026-2034??)
7.6 Others
7.6.1 Historical and Current Market Trends ???(??2020-2025?)
7.6.2 Market Forecast ???(?2026-2034??)
8 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET - BREAKUP BY APPLICATION
8.1 Infectious Diseases Diagnostics
8.1.1 Overview
8.1.2 Historical and Current Market Trends ???(??2020-2025?)
8.1.3 Market Forecast ???(?2026-2034??)
8.2 Oncology
8.2.1 Overview
8.2.2 Historical and Current Market Trends ???(??2020-2025?)
8.2.3 Market Forecast ???(?2026-2034??)
8.3 Genetic Testing
8.3.1 Overview
8.3.2 Historical and Current Market Trends ???(??2020-2025?)
8.3.3 Market Forecast ???(?2026-2034??)
8.4 Blood Screening
8.4.1 Overview
8.4.2 Historical and Current Market Trends ???(??2020-2025?)
8.4.3 Market Forecast ???(?2026-2034??)
8.5 Others
8.5.1 Historical and Current Market Trends ???(??2020-2025?)
8.5.2 Market Forecast ???(?2026-2034??)
9 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET - BREAKUP BY END USER
9.1 Hospitals
9.1.1 Overview
9.1.2 Historical and Current Market Trends ???(??2020-2025?)
9.1.3 Market Forecast ???(?2026-2034??)
9.2 Laboratories
9.2.1 Overview
9.2.2 Historical and Current Market Trends ???(??2020-2025?)
9.2.3 Market Forecast ???(?2026-2034??)
9.3 Others
9.3.1 Historical and Current Market Trends ???(??2020-2025?)
9.3.2 Market Forecast ???(?2026-2034??)
10 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET – BREAKUP BY REGION
10.1 Seoul Capital Area
10.1.1 Overview
10.1.2 Historical and Current Market Trends ???(??2020-2025?)
10.1.3 Market Breakup by Product
10.1.4 Market Breakup by Technology
10.1.5 Market Breakup by Application
10.1.6 Market Breakup by End User
10.1.7 Key Players
10.1.8 Market Forecast ???(?2026-2034??)
10.2 Yeongnam (Southeastern Region)
10.2.1 Overview
10.2.2 Historical and Current Market Trends ???(??2020-2025?)
10.2.3 Market Breakup by Product
10.2.4 Market Breakup by Technology
10.2.5 Market Breakup by Application
10.2.6 Market Breakup by End User
10.2.7 Key Players
10.2.8 Market Forecast ???(?2026-2034??)
10.3 Honam (Southwestern Region)
10.3.1 Overview
10.3.2 Historical and Current Market Trends ???(??2020-2025?)
10.3.3 Market Breakup by Product
10.3.4 Market Breakup by Technology
10.3.5 Market Breakup by Application
10.3.6 Market Breakup by End User
10.3.7 Key Players
10.3.8 Market Forecast ???(?2026-2034??)
10.4 Hoseo (Central Region)
10.4.1 Overview
10.4.2 Historical and Current Market Trends ???(??2020-2025?)
10.4.3 Market Breakup by Product
10.4.4 Market Breakup by Technology
10.4.5 Market Breakup by Application
10.4.6 Market Breakup by End User
10.4.7 Key Players
10.4.8 Market Forecast ???(?2026-2034??)
10.5 Others
10.5.1 Historical and Current Market Trends ???(??2020-2025?)
10.5.2 Market Forecast ???(?2026-2034??)
11 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET – COMPETITIVE LANDSCAPE
11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant
12 PROFILES OF KEY PLAYERS
12.1 Company A
12.1.1 Business Overview
12.1.2 Products Offered
12.1.3 Business Strategies
12.1.4 SWOT Analysis
12.1.5 Major News and Events
12.2 Company B
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Business Strategies
12.2.4 SWOT Analysis
12.2.5 Major News and Events
12.3 Company C
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Business Strategies
12.3.4 SWOT Analysis
12.3.5 Major News and Events
12.4 Company D
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Business Strategies
12.4.4 SWOT Analysis
12.4.5 Major News and Events
12.5 Company E
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Business Strategies
12.5.4 SWOT Analysis
12.5.5 Major News and Events
13 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET - INDUSTRY ANALYSIS
13.1 Drivers, Restraints, and Opportunities
13.1.1 Overview
13.1.2 Drivers
13.1.3 Restraints
13.1.4 Opportunities
13.2 Porters Five Forces Analysis
13.2.1 Overview
13.2.2 Bargaining Power of Buyers
13.2.3 Bargaining Power of Suppliers
13.2.4 Degree of Competition
13.2.5 Threat of New Entrants
13.2.6 Threat of Substitutes
13.3 Value Chain Analysis
14 APPENDIX
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET LANDSCAPE
5.1 Historical and Current Market Trends ???(??2020-2025?)
5.2 Market Forecast ???(?2026-2034??)
6 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET - BREAKUP BY PRODUCT
6.1 Reagents and Kits
6.1.1 Overview
6.1.2 Historical and Current Market Trends ???(??2020-2025?)
6.1.3 Market Forecast ???(?2026-2034??)
6.2 Instruments
6.2.1 Overview
6.2.2 Historical and Current Market Trends ???(??2020-2025?)
6.2.3 Market Forecast ???(?2026-2034??)
6.3 Software and Services
6.3.1 Overview
6.3.2 Historical and Current Market Trends ???(??2020-2025?)
6.3.3 Market Forecast ???(?2026-2034??)
7 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET - BREAKUP BY TECHNOLOGY
7.1 Polymerase Chain Reactions (PCR)
7.1.1 Overview
7.1.2 Historical and Current Market Trends ???(??2020-2025?)
7.1.3 Market Forecast ???(?2026-2034??)
7.2 Hybridization
7.2.1 Overview
7.2.2 Historical and Current Market Trends ???(??2020-2025?)
7.2.3 Market Forecast ???(?2026-2034??)
7.3 DNA Sequencing
7.3.1 Overview
7.3.2 Historical and Current Market Trends ???(??2020-2025?)
7.3.3 Market Forecast ???(?2026-2034??)
7.4 Microarray
7.4.1 Overview
7.4.2 Historical and Current Market Trends ???(??2020-2025?)
7.4.3 Market Forecast ???(?2026-2034??)
7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.5.1 Overview
7.5.2 Historical and Current Market Trends ???(??2020-2025?)
7.5.3 Market Forecast ???(?2026-2034??)
7.6 Others
7.6.1 Historical and Current Market Trends ???(??2020-2025?)
7.6.2 Market Forecast ???(?2026-2034??)
8 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET - BREAKUP BY APPLICATION
8.1 Infectious Diseases Diagnostics
8.1.1 Overview
8.1.2 Historical and Current Market Trends ???(??2020-2025?)
8.1.3 Market Forecast ???(?2026-2034??)
8.2 Oncology
8.2.1 Overview
8.2.2 Historical and Current Market Trends ???(??2020-2025?)
8.2.3 Market Forecast ???(?2026-2034??)
8.3 Genetic Testing
8.3.1 Overview
8.3.2 Historical and Current Market Trends ???(??2020-2025?)
8.3.3 Market Forecast ???(?2026-2034??)
8.4 Blood Screening
8.4.1 Overview
8.4.2 Historical and Current Market Trends ???(??2020-2025?)
8.4.3 Market Forecast ???(?2026-2034??)
8.5 Others
8.5.1 Historical and Current Market Trends ???(??2020-2025?)
8.5.2 Market Forecast ???(?2026-2034??)
9 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET - BREAKUP BY END USER
9.1 Hospitals
9.1.1 Overview
9.1.2 Historical and Current Market Trends ???(??2020-2025?)
9.1.3 Market Forecast ???(?2026-2034??)
9.2 Laboratories
9.2.1 Overview
9.2.2 Historical and Current Market Trends ???(??2020-2025?)
9.2.3 Market Forecast ???(?2026-2034??)
9.3 Others
9.3.1 Historical and Current Market Trends ???(??2020-2025?)
9.3.2 Market Forecast ???(?2026-2034??)
10 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET – BREAKUP BY REGION
10.1 Seoul Capital Area
10.1.1 Overview
10.1.2 Historical and Current Market Trends ???(??2020-2025?)
10.1.3 Market Breakup by Product
10.1.4 Market Breakup by Technology
10.1.5 Market Breakup by Application
10.1.6 Market Breakup by End User
10.1.7 Key Players
10.1.8 Market Forecast ???(?2026-2034??)
10.2 Yeongnam (Southeastern Region)
10.2.1 Overview
10.2.2 Historical and Current Market Trends ???(??2020-2025?)
10.2.3 Market Breakup by Product
10.2.4 Market Breakup by Technology
10.2.5 Market Breakup by Application
10.2.6 Market Breakup by End User
10.2.7 Key Players
10.2.8 Market Forecast ???(?2026-2034??)
10.3 Honam (Southwestern Region)
10.3.1 Overview
10.3.2 Historical and Current Market Trends ???(??2020-2025?)
10.3.3 Market Breakup by Product
10.3.4 Market Breakup by Technology
10.3.5 Market Breakup by Application
10.3.6 Market Breakup by End User
10.3.7 Key Players
10.3.8 Market Forecast ???(?2026-2034??)
10.4 Hoseo (Central Region)
10.4.1 Overview
10.4.2 Historical and Current Market Trends ???(??2020-2025?)
10.4.3 Market Breakup by Product
10.4.4 Market Breakup by Technology
10.4.5 Market Breakup by Application
10.4.6 Market Breakup by End User
10.4.7 Key Players
10.4.8 Market Forecast ???(?2026-2034??)
10.5 Others
10.5.1 Historical and Current Market Trends ???(??2020-2025?)
10.5.2 Market Forecast ???(?2026-2034??)
11 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET – COMPETITIVE LANDSCAPE
11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant
12 PROFILES OF KEY PLAYERS
12.1 Company A
12.1.1 Business Overview
12.1.2 Products Offered
12.1.3 Business Strategies
12.1.4 SWOT Analysis
12.1.5 Major News and Events
12.2 Company B
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Business Strategies
12.2.4 SWOT Analysis
12.2.5 Major News and Events
12.3 Company C
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Business Strategies
12.3.4 SWOT Analysis
12.3.5 Major News and Events
12.4 Company D
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Business Strategies
12.4.4 SWOT Analysis
12.4.5 Major News and Events
12.5 Company E
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Business Strategies
12.5.4 SWOT Analysis
12.5.5 Major News and Events
13 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET - INDUSTRY ANALYSIS
13.1 Drivers, Restraints, and Opportunities
13.1.1 Overview
13.1.2 Drivers
13.1.3 Restraints
13.1.4 Opportunities
13.2 Porters Five Forces Analysis
13.2.1 Overview
13.2.2 Bargaining Power of Buyers
13.2.3 Bargaining Power of Suppliers
13.2.4 Degree of Competition
13.2.5 Threat of New Entrants
13.2.6 Threat of Substitutes
13.3 Value Chain Analysis
14 APPENDIX
